Overview

Venlafaxine PK Following Bariatric Surgery

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate how the body absorbs and processes the immediate release (IR) and sustained release (XR) medication venlafaxine (Effexor®). Subject who are 1-3 years post gastric bypass or sleeve gastrectomy surgery will be invited to participate. Non-surgical controls will also be enrolled based on a matching criteria to post gastric bypass subjects. Participants will be asked to complete two 12-hour study days approximately 11 days apart. This study will enroll up to 30 participants.
Phase:
Phase 4
Details
Lead Sponsor:
North Dakota State University
Collaborator:
Neuropsychiatric Research Institute, Fargo, North Dakota
Treatments:
Venlafaxine Hydrochloride